-+ 0.00%
-+ 0.00%
-+ 0.00%

NERVGEN PHARMA CORP : LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING; PRICE TARGET $10

Reuters·07/13/2026 10:07:00

Please log in to view news